Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Hüseyin AtacanDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.ORCID 0000-0002-1472-6924
Volkan AslanDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.ORCID 0000-0001-5685-3748
Alper TopalDepartment of Medical Oncology, Tokat Gaziosmanpaşa University, Tokat 60150, Türkiye.ORCID 0000-0002-9679-9245
Nurlan MammadzadaDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.ORCID 0000-0003-1981-7144
Gizem YıldırımDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.
Gökçe Gül GüneysuDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.
Berkan KaradurmuşDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.ORCID 0000-0002-4821-8143
Esmanur Kaplan TüzünDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.
Ömer Faruk KuzuDepartment of Medical Oncology, Çankırı State Hospital, Çankırı 18100, Türkiye.ORCID 0000-0003-3197-7861
Efe Cem ErdatDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.ORCID 0000-0002-1250-1297
Musa Barış AykanDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.ORCID 0000-0001-7538-9119
İsmail ErtürkDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.
Nuri KaradurmuşDepartment of Medical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Pre-Transplant Prognostic Nutritional Index Independently Predicts Progression-Free Survival After Autologous Stem Cell Transplantation in Lymphoma. · full record | OpenQuestion